Anthropic says its Claude AI identified a previously unknown enzyme system in DNA that resembles CRISPR gene-editing machinery, including components that appear similar to Cas9. The company frames the discovery as something Claude located autonomously, based on patterns in biological data.
Both outlets report that Anthropic does not yet know what the system actually does. Even Anthropic leadership, including Dario Amodei, is cited as acknowledging that the enzyme’s function remains undetermined. While the system is described as “CRISPR-like,” the resemblance does not automatically mean it can perform gene editing in the way Cas9 does. As a result, the reports emphasize that more analysis and validation are needed to determine the biological role and potential capabilities of the newly identified system.
Gizmodo highlights the uncertainty and cautions that “looks can be deceiving,” while Decrypt focuses on the scale of the claim alongside the absence of functional details. Across both accounts, the shared angle is that the discovery is real in terms of identification, but scientific interpretation is not yet established.
